MedPath

Covered or Uncovered Bile Duct Stents

Not Applicable
Completed
Conditions
Bile Duct Neoplasms
Interventions
Device: covered or uncovered stents
Registration Number
NCT01232101
Lead Sponsor
Göteborg University
Brief Summary

The study is investigator initiated. Tumors that gives the narrowing of the bile ducts prevents bile from flowing from the liver to the intestine resulting in jaundice and the risk of bacterial growth in bile with severe infections as a result. Unresectable bile duct strictures have routinely been treated them with plastic stents. The plastic stents have been replaced by self expandable metallic stents.

These stents remain open longer for reasons that they have a larger diameter so that the bile flows through more easily. One problem with these stents, however, is that the tumor growing through the wire mesh which forms the wall of the stent. This has led to the development of so-called covered stents. Whether covered stents have longer patency is unclear as well as whether they are as safe. There is reason to believe that covered stents remain open longer, but there may be an increased risk of migration and other complications.

The purpose is to prospectively and randomized compare the two stent types. The study endpoint is the clogging of the stent or the patient's death. We also monitor complications, regress time of the jaundice and success rate of stent placement

Detailed Description

0

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
71
Inclusion Criteria
  • Patients with unresectable, distal bile duct stricture needing relieved endoscopically
  • Expected survival greater than 3 months
  • The patient must give written consent to participate in the study
Exclusion Criteria
  • Stricture close to hilus
  • Need for interpreter

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
covered self expandable metallic stentscovered or uncovered stentsPatients with bile malignant bile duct strictures are randomized to covered or uncovered stent
Uncovered self expandable metallic stentcovered or uncovered stents-
Primary Outcome Measures
NameTimeMethod
The primary aim of the present study was to compare and stent patency between covered and uncovered bileduct SEMSStent occlusion or patient death
Secondary Outcome Measures
NameTimeMethod
Secondary objectives were to study difference in technical success, efficacy of drainage and complication rate between covered and uncovered metal stentsEvaluated within three days

Trial Locations

Locations (1)

Kjell-Arne Ung, Dpt of Internal Medicine, Karnsjukhuset,

🇸🇪

Skovde, Sweden

© Copyright 2025. All Rights Reserved by MedPath